Research Areas
In ths section, by far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.
| Axon ID | Name | Description | From price | |
|---|---|---|---|---|
| 1179 | A1B1 hydrochloride | CCR1 antagonist | €125.00 | |
| 1738 | AMD 3100 | CXCR4 antagonist | €85.00 | |
| 1930 | AMD 3465 hexahydrobromide | Potent and selective CXCR4 antagonist | €85.00 | |
| 2842 | AZD 2098 | Potent, selective and bioavailable CCR4 receptor antagonist | €125.00 | |
| 2255 | AZD 8797 | Potent and selective antagonist of the Fractalkine receptor (FKN or CX3CR1) | €120.00 | |
| 2082 | BX 471 | Selective CCR1 receptor antagonist | €105.00 | |
| 2665 | Cenicriviroc | Oral CCR5-antagonist for treatment of HIV infection | €145.00 | |
| 1800 | CXCR3 Antagonist 6c | CXCR3 antagonist | €135.00 | |
| 2921 | LIT-927 | Selective, locally and orally active CXCL12 neutraligand | €95.00 | |
| 1559 | SB 265610 | CXCR2 antagonist | €95.00 | |
| 2593 | SB 332235 | Nonpeptide CXCR2 antagonist exhibiting significant anti-inflammatory effects | €105.00 | |
| 2993 | UNBS5162 | Pan-antagonist of CXCL chemokine expression | €95.00 | |
| 2685 | Vercirnon | CCR9 antagonist | €135.00 | |
| 1620 | WZ 811 | CXCR4 antagonist | €80.00 | |
| 2636 | YJC-10592 | CCR2 antagonist | €145.00 | |